Muller and colleagues64 reported on the use of anti-p52 IgM and anti-gB IgG compared to routine IgG, IgM, and avidity assays during pregnancy to return “conclusive results” (i.e., susceptible to infection, acute primary infection, recurrent infection/reactivation, or past infection). This evidence concerns the gene CD40LG and infection.